Acute Heart Failure in a Patient with Occult Barlow’s Disease Receiving Bevacizumab
Bevacizumab is a recombinant humanized monoclonal antibody and a key drug for treatment of various types of cancer. Bevacizumab is associated with the occurrence of heart failure, but its risk factors remain unknown. A 55-year-old woman was diagnosed with cervical cancer, which was completely treate...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2021-09-01
|
| Saila: | Medicina |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/1648-9144/57/10/998 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|